AstraZeneca Files Routine 6-K Report
Ticker: AZN · Form: 6-K · Filed: Sep 2, 2025 · CIK: 901832
| Field | Detail |
|---|---|
| Company | Astrazeneca PLC (AZN) |
| Form Type | 6-K |
| Filed Date | Sep 2, 2025 |
| Risk Level | low |
| Pages | 2 |
| Reading Time | 2 min |
| Key Dollar Amounts | $0.25 |
| Sentiment | neutral |
Sentiment: neutral
Topics: sec-filing, foreign-issuer, routine-report
Related Tickers: AZN
TL;DR
AZN filed a standard 6-K, no major news.
AI Summary
AstraZeneca PLC filed a Form 6-K on September 2, 2025, reporting for the month of September 2025. The company, registered under SEC file number 001-11960, is a foreign issuer based in Cambridge, United Kingdom, and files annual reports under Form 20-F. The filing does not contain specific financial figures or operational updates beyond its routine reporting status.
Why It Matters
This filing indicates AstraZeneca is fulfilling its regular reporting obligations to the SEC as a foreign issuer, which is standard practice for publicly traded companies.
Risk Assessment
Risk Level: low — This is a routine filing by AstraZeneca PLC to report as a foreign issuer, not containing any material new information or significant financial events.
Key Players & Entities
- AstraZeneca PLC (company) — Filer of the report
- 001-11960 (dollar_amount) — SEC File Number
- September 2025 (date) — Reporting period
- 20-F (company) — Annual report form
FAQ
What type of report is AstraZeneca PLC filing?
AstraZeneca PLC is filing a Form 6-K, which is a Report of Foreign Issuer.
What is the SEC file number for AstraZeneca PLC?
The SEC file number for AstraZeneca PLC is 001-11960.
For which month is this Form 6-K report being filed?
This Form 6-K report is being filed for the month of September 2025.
Where is AstraZeneca PLC's business address listed?
AstraZeneca PLC's business address is listed as 1 Francis Crick Avenue, Cambridge Biomedical Campus, Cambridge CB2 0AA, United Kingdom.
Does AstraZeneca PLC file annual reports under Form 20-F or Form 40-F?
AstraZeneca PLC indicates it files annual reports under cover of Form 20-F.
Filing Stats: 507 words · 2 min read · ~2 pages · Grade level 14.7 · Accepted 2025-09-02 06:17:16
Key Financial Figures
- $0.25 — s is 1,550,692,963 ordinary shares of US$0.25. No shares are held in Treasury. Theref
Filing Documents
- a3337x.htm (6-K) — 19KB
- 0001654954-25-010235.txt ( ) — 20KB
SIGNATURES
SIGNATURES   Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.     AstraZeneca PLC     Date: 01 September 2025     By: /s/ Matthew Bowden   Name: Matthew Bowden   Title: Company Secretary